After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP)

Transfusion and Apheresis Science

Volumn 30, Issue 2, 2004, Pages 105-110

  Enrique Rewald, M D ^a   Francischetti, M M ^a  

^a NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; RHESUS D ANTIBODY; VINCRISTINE;

AGED; ARTICLE; BLEEDING; CASE REPORT; CHRONIC DISEASE; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOW DRUG DOSE; PANCYTOPENIA; PATIENT; SENESCENCE; SPLENOMEGALY; SYMPTOM; THROMBOCYTE COUNT;

AGED; FEMALE; HEMOLYSIS; HUMANS; INFUSIONS, INTRAVENOUS; ISOANTIBODIES; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RHO(D) IMMUNE GLOBULIN; TIME FACTORS;

EID: 1942518778     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.09.001     Document Type: Article

References (19)

1. Rewald E., Francischetti M.M. Methotrexate treatment and mortality in rheumatoid arthritis. Lancet. 360:2002;1097.
2. Barbolla L., Nieto S., Llamas P., Moreno C., Contreras M., Lubenko A.et al. Severe immune haemolytic anaemia caused by intravenous immunoglobulin anti-D in the treatment of autoimmune thrombocytopenia. Vox Sang. 64:1993;184-185.
3. Semple J.W. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 16:2002;9-12.
4. 0(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood. 95:2000;2523-2529.
5. Malinowska I., Obitko-Pludowska A., Buescher E.S., Wasik M., Rokicka-Milewska R. Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura. Hematol. J. 2:2001;242-249.
6. Amital H., Rewald E., Levy Y., Bar-Dayan Y., Manthorpe R., Engervall P. et al. Fibrosis regression induced by intravenous gammaglobulin treatment. Ann. Rheum. Dis. 62:2003;175-177.
7. Levendoglu-Tugal O., Jayabose S.J. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia. Pediatr. Hematol. Oncol. 23:2001;460-463.
8. Kees-Folts D., Abt A.B., Domen R.E., Freiberg A.S. Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura. Pediatr. Nephrol. 17:2002;91-96.
9. Kumpel B.M., Elson C.J. Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends Immunol. 22:2001;26-31.
10. Ballot-Brossier C, Mortelecque R, Sinegre M, Marceau A, Dauriat G, Courtois F. [Insisting on intravenous polyvalent immunoglobulin therapy in polymyositis in spite of the occurrence of severe hemolytic anemia] French. Transfus Clin Biol 2001;8:94-99
11. Mollison P.L., Engelfriet C.P., Contreras M. Blood transfusion in clinical medicine. 8th ed. 1987;Blackwell Scientific Publications, Oxford. p.671.
12. Sandler S.G. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura. Curr. Opin. Hematol. 8:2001;417-420.
13. Rewald E. Repeated low doses of anti-rhesus gammaglobulin in aplastic anaemia. Lancet. 2:1987;795.
14. Rewald E. A vascular effect of IgG therapy may prevent transplacental red cell leakage and spontaneous thrombocytopenic haemorrhages. Med. Hypotheses. 33:1990;193-195.
15. Terness P., Opelz G. Regulation of antibody response by an IgG-anti-Ig autoantibody occurring during alloimmunization. I. A few IgG molecules inactivate one B cell. Transplantation. 54:1992;88-91.
16. Frommel D., Grob P.J., Masouredis S.P., Isliker H.C. Studies on the mechanism of immunoglobulin binding to red cells. Immunology. 13:1967;501-508.
17. Bakacs T., Kimber I., Moore M., Human K. Cell-mediated haemolysis: determination of the cytotoxic capacity and antibody sensitization requirements of T lymphocyte enriched and depleted populations. J. Clin. Lab. Immunol. 12:1983;209-215.
18. Shapiro S., Kohn D., Miller B., Gershon H. Erythrocytes from young but not elderly donors can bind and degrade immune complex- and antibody-bound C3 in vitro. Clin. Exp. Immunol. 95:1994;181-190.
19. Rewald E., Francischetti M.M., Nydegger U.E. IVIG-pools: regulatory gifts - transiting from harmony toward harmonious immunoglobulins: why? and why not? Transfus. Apher. Sci. 25:2001;113-137.